A detailed history of Neuberger Berman Group LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 27,316 shares of PACB stock, worth $52,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,316
Holding current value
$52,719
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $713,346 - $1.29 Million
-594,455 Reduced 95.61%
27,316 $46,000
Q4 2023

Nov 14, 2024

BUY
$5.97 - $10.36 $3.71 Million - $6.44 Million
621,771 New
621,771 $6.1 Million
Q4 2023

Feb 09, 2024

BUY
$5.97 - $10.36 $857,656 - $1.49 Million
143,661 Added 30.05%
621,771 $6.1 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $537,921 - $910,478
65,361 Added 15.84%
478,110 $3.99 Million
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $4.12 Million - $5.8 Million
412,749 New
412,749 $5.49 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.